Immunologic Monitoring of Cancer Vaccine Trials Using the ELISPOT Assay
We present the Interferon (IFN)-γ-producing lymphocyte assay, but the platform is easily adjusted to several cell types and several secreted molecules.
Source: Springer protocols feed by Cancer Research - Category: Cancer & Oncology Source Type: news
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Cancer Vaccines | Laboratory Medicine | Melanoma | Skin Cancer | Vaccines